The 131st Annual Meeting (November 15-19, 2003) of APHA

The 131st Annual Meeting (November 15-19, 2003) of APHA

4259.0: Tuesday, November 18, 2003 - 5:30 PM

Abstract #70575

Role of special interest groups in influencing data on risk

Lisa A. Bero, PhD, Institute for Health Policy Studies, Department of Clinical Pharmacy, and Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, Box 1390, Library, San Francisco, CA 94143, 415-476-1067, bero@medicine.ucsf.EDU

Research findings, often from basic science, epidemiology, and exposure or engineering research, provide the basis of information on risk. However, these research findings or “facts” are subject to interpretation. Furthermore, scientific uncertainties allow for a wide range of interpretation of the same data. Since data do not “speak for themselves,”special interest groups can play a critical role in interpreting the research evidence on risk. This presentation will focus on several case studies describing how special interest groups have influenced the collection, interpretation, and dissemination of data on risk, including examples of particular tactics used. Many of the strategies available to special interest groups for example, sponsoring, publishing and criticizing research are costly, and may therefore be relatively more available to industry groups than advocacy groups.

Learning Objectives:

Keywords: Risk Assessment, Research Ethics

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

Social Determinants of Health - Sound Science for Sale? Industry Influence over Research, Risk Assessment and Regulation of Tobacco, Food and Toxic Chemicals

The 131st Annual Meeting (November 15-19, 2003) of APHA